Literature DB >> 8839720

Dyslipidaemia in a boy with recurrent abdominal pain, hypersalivation and decreased lipoprotein lipase activity.

D Matern1, H Seydewitz, H Niederhoff, H Wiebusch, M Brandis.   

Abstract

UNLABELLED: An 8-year-old boy with frequently recurring pancreatitis-like abdominal pain, Fredrickson type V dyslipidaemia, and significantly decreased post-heparin plasma lipoprotein lipase (LPL) activity is described. In order to exclude familial LPL deficiency, the complete LPL coding gene sequence was analysed revealing compound heterozygosity for two mutations (Asp9Asn, Ser447Ter) which are not supposed to considerably impair lipolytic enzyme activity. However, until now the combination of both these mutations in one patient has not been observed. In addition to the common symptoms of LPL deficiency, a striking feature of unknown origin was hypersalivation. Treatment including a fat-restricted diet, omega-3 fatty acids, and nicotinic acid led to long symptoms-free intervals. Symptoms recurred however when the diet was not strictly adhered to.
CONCLUSION: LPL deficiency is a rare cause of abdominal pain in childhood and deserves careful treatment in order to avoid pancreatitis. The presented patients is a unique compound heterozygote for two mutations which do not abolish lipolytic activity in the homozygote state. Identification of other individuals with this genotype is necessary to understand the phenotype in our patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839720     DOI: 10.1007/bf01957148

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene.

Authors:  A Hata; M Robertson; M Emi; J M Lalouel
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

Review 2.  [Chylomicronemia syndrome--pathophysiology, clinical aspects and therapy].

Authors:  H U Klör
Journal:  Klin Wochenschr       Date:  1990

3.  Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA.

Authors:  T Hultman; S Bergh; T Moks; M Uhlén
Journal:  Biotechniques       Date:  1991-01       Impact factor: 1.993

4.  A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.

Authors:  Y Ma; H E Henderson; V Murthy; G Roederer; M V Monsalve; L A Clarke; T Normand; P Julien; C Gagné; M Lambert
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

5.  Improved phenotyping of apolipoprotein E: application to population frequency distribution.

Authors:  J S Hill; P H Pritchard
Journal:  Clin Chem       Date:  1990-11       Impact factor: 8.327

6.  Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.

Authors:  I Gouni; K Oka; J Etienne; L Chan
Journal:  J Lipid Res       Date:  1993-01       Impact factor: 5.922

7.  Structure-function relationships of lipoprotein lipase: mutation analysis and mutagenesis of the loop region.

Authors:  H E Henderson; Y Ma; M S Liu; I Clark-Lewis; D L Maeder; J J Kastelein; J D Brunzell; M R Hayden
Journal:  J Lipid Res       Date:  1993-09       Impact factor: 5.922

8.  Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T).

Authors:  H Wiebusch; J R Nofer; A von Eckardstein; H Funke; U Wahrburg; H Martin; E Köhler; G Assmann
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

9.  A heterozygous mutation (the codon for Ser447----a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia.

Authors:  J Kobayashi; T Nishida; D Ameis; G Stahnke; M C Schotz; H Hashimoto; I Fukamachi; K Shirai; Y Saito; S Yoshida
Journal:  Biochem Biophys Res Commun       Date:  1992-01-15       Impact factor: 3.575

10.  A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.

Authors:  F Mailly; Y Tugrul; P W Reymer; T Bruin; M Seed; B F Groenemeyer; A Asplund-Carlson; D Vallance; A F Winder; G J Miller
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.